Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Summary

This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of dapsone in subjects with acne vulgaris following 28 days of dosing.

Timeline

Start

2013-01-21

Primary completion

2013-05-05

Completion

2013-05-05

Publications

• Background Jarratt MT, Jones TM, Chang-Lin JE, Tong W, Berk DR, Lin V, Kaoukhov A. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris. J Drugs Dermatol. 2016 Oct 1;15(10):1250-1259.

Drugs

Indications